Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry

BACKGROUND: We aimed to describe physician practice patterns in holding or continuing IBD therapy in the setting of COVID-19 infection, using the Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease [SECURE-IBD] registry. METHODS: IBD medications that were...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrawal, Manasi, Brenner, Erica J, Zhang, Xian, Colombel, Jean-Frederic, Kappelman, Michael D, Ungaro, Ryan C, Gearry, Richard B, Kalpan, Gilaad G, Kissous-Hunt, Michele, Lewis, James D, Ng, Siew C, Rahier, Jean-Francois, Reinisch, Walter, Ruemmele, Frank M, Steinwurz, Flavio, Underwood, Fox E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717203/
https://www.ncbi.nlm.nih.gov/pubmed/33232456
http://dx.doi.org/10.1093/ecco-jcc/jjaa243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717203/
https://www.ncbi.nlm.nih.gov/pubmed/33232456
http://dx.doi.org/10.1093/ecco-jcc/jjaa243

Ejemplares similares